Dr. Menco is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
227 W Janss Rd
# 310
Thousand Oaks, CA 91360Phone+1 805-496-2949Fax+1 805-496-1844
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1985 - 1987
- MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1982 - 1985
- University of Amsterdam Faculty of MedicineClass of 1981
Certifications & Licensure
- CA State Medical License 1985 - 2023
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 9 citationsExcellent tolerance of rituximab when given after mitoxantrone/cyclophosphamide: an effective and safe combination for indolent non-Hodgkin's lymphoma.Christos Emmanouilides, Peter Rosen, Milhan Telatar, R. Malone, Linda D. Bosserman
Clinical Lymphoma. 2000-09-01 - 3 citationsMitoxantrone-cyclophosphamide-rituximab: an effective and safe combination for indolent NHL.Christos Emmanouilides, Mary C. Territo, H. Menco, Ravi Patel, Peter Rosen
Hematological Oncology. 2003-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: